AU1346501A - Methods for improving viral vector titers and reducing cell death in cell cultures - Google Patents
Methods for improving viral vector titers and reducing cell death in cell culturesInfo
- Publication number
- AU1346501A AU1346501A AU13465/01A AU1346501A AU1346501A AU 1346501 A AU1346501 A AU 1346501A AU 13465/01 A AU13465/01 A AU 13465/01A AU 1346501 A AU1346501 A AU 1346501A AU 1346501 A AU1346501 A AU 1346501A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- viral vector
- vector titers
- cell death
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36141—Use of virus, viral particle or viral elements as a vector
- C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16234699P | 1999-10-29 | 1999-10-29 | |
US60162346 | 1999-10-29 | ||
PCT/US2000/029549 WO2001032838A2 (en) | 1999-10-29 | 2000-10-27 | Methods for improving viral vector titers and reducing cell death in cell cultures |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1346501A true AU1346501A (en) | 2001-05-14 |
Family
ID=22585237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU13465/01A Abandoned AU1346501A (en) | 1999-10-29 | 2000-10-27 | Methods for improving viral vector titers and reducing cell death in cell cultures |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1224260A2 (en) |
JP (1) | JP2003513623A (en) |
AU (1) | AU1346501A (en) |
CA (1) | CA2389057A1 (en) |
WO (1) | WO2001032838A2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU632065B2 (en) * | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
JPH0856655A (en) * | 1994-08-16 | 1996-03-05 | Frontier:Kk | Cytocidal agent and cell death preventive agent |
FR2744455B1 (en) * | 1996-02-02 | 1998-04-24 | Sanofi Sa | NOVEL NUCLEIC ACID SEQUENCES OF THE FAMILY OF TUMOR SUPPRESSOR FACTORS, CORRESPONDING EXPRESSION PRODUCTS AND THEIR APPLICATIONS |
-
2000
- 2000-10-27 JP JP2001535520A patent/JP2003513623A/en not_active Withdrawn
- 2000-10-27 WO PCT/US2000/029549 patent/WO2001032838A2/en not_active Application Discontinuation
- 2000-10-27 EP EP00975409A patent/EP1224260A2/en not_active Withdrawn
- 2000-10-27 CA CA002389057A patent/CA2389057A1/en not_active Abandoned
- 2000-10-27 AU AU13465/01A patent/AU1346501A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1224260A2 (en) | 2002-07-24 |
WO2001032838A2 (en) | 2001-05-10 |
CA2389057A1 (en) | 2001-05-10 |
JP2003513623A (en) | 2003-04-15 |
WO2001032838A3 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001236042A1 (en) | Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell | |
AU2002338666A1 (en) | Multiplication of viruses in a cell culture | |
AU2001282908A1 (en) | Bioreactor and bioprocessing technique | |
AU5444800A (en) | LTiGTin vitroLT/iGT cell culture device including cartilage and methods of usingthe same | |
AU6512299A (en) | Gemini virus vectors for gene expression in plants | |
AU4965799A (en) | Bioreactor and cell culturing processes using the bioreactor | |
EP1385933A4 (en) | Culture medium for cell growth and transfection | |
HUP0201887A2 (en) | Conditioned cell culture medium compositions and methods of use | |
AU6860301A (en) | Methods and compositions for simultaneous saccharification and fermentation | |
AU2864100A (en) | Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products | |
AU2001294520A1 (en) | Methods and compositions for increasing protein yield from a cell culture | |
AU2002325758A1 (en) | Cultured stromal cells and uses thereof | |
AU7261898A (en) | Methods for viral inactivation and compositions for use in same | |
AU2002230459A1 (en) | Cell culture apparatus and methods of use | |
HK1045328A1 (en) | Recombinant hosts suitable for simultaneous saccharification and fermentation | |
AU1864999A (en) | Methods and compositions for improving the success of cell transplantation in a host | |
AU1346501A (en) | Methods for improving viral vector titers and reducing cell death in cell cultures | |
AU2002225693A1 (en) | Optimized antitrypsin expression in rice cell culture | |
AU7954500A (en) | Method of in vitro culture of lymphocytes and gene therapy compositions | |
EP1221853A4 (en) | Oligodendrocyte cell cultures and methods for their preparation and use | |
AU4771600A (en) | Cells, culture methods and their uses | |
AU2001289603A1 (en) | Methods and means for the complementation of viral protein expression in stable cell lines | |
AU1224601A (en) | In vitro embryo culture device and methods | |
AU2002230479A1 (en) | Cell culture apparatus and methods of use | |
AU1604701A (en) | Mammalian genes; related reagents and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |